Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 2Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Gliosarcoma 1Glioblastoma 1Esophageal Squamous Cell Carcinoma 1Central Nervous System Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Brain Neoplasms 1Astrocytoma 1Adenocarcinoma Of Esophagus 1

Interventions

Temozolomide 11Radiotherapy 10Cisplatin 4Carmustine 4Vincristine 3Surgical Procedures, Operative 3Methotrexate 3Lomustine 3Chlorotoxin 3Carboplatin 3Thiotepa 2Etoposide 2Cyclophosphamide 2Chemotherapy, Adjuvant 2Amplified Fragment Length Polymorphism Analysis 2lonafarnib 1interleukin-4-Pseudomonas exotoxin 1Verteporfin 1Valproic Acid 1Tranexamic Acid 1Tf-CRM107 1Tamoxifen 1Procarbazine 1Prednisone 1Peripheral Blood Stem Cell Transplantation 1Pemetrexed 1Neoadjuvant Therapy 1Metformin 1Metabolism 1Magnetic Resonance Spectroscopy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Astrocytoma × Dihematoporphyrin Ether × Clear all
NCT00003788 2013-11-06

Surgery, Radiation Therapy, and Chemotherapy With or Without Photodynamic Therapy in Treating Patients With Newly Diagnosed or Recurrent Malignant Supratentorial Gliomas

National Cancer Institute (NCI)

Phase 3 Unknown
270 enrolled
CNSSarcoma

Astrocytoma, Brain Neoplasms, Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡